Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001816518 | SCV002063264 | uncertain significance | not provided | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002541948 | SCV002976488 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2022-04-20 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001816518 | SCV005410839 | uncertain significance | not provided | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004733382 | SCV005355709 | uncertain significance | SETX-related disorder | 2024-07-23 | no assertion criteria provided | clinical testing | The SETX c.7720G>A variant is predicted to result in the amino acid substitution p.Glu2574Lys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0050% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |